Raynaud-Phänomen - Aktuelle Diagnostik und Therapie

Schlüsselwörter

Raynaud-Phänomen - akrale Vasospastik - Sklerodermie - Vibrationssyndrom

Key words

Raynaud’s phenomenon - digital vasospasm - scleroderma - vibration white finger syndrome

Literatur

• 1 Anderson M E, Moore T L. et al . Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud’s phenomenon and systemic sclerosis.  Rheumatology. 2002;  41 324-328
• 2 Appiah R, Hiller H, Caspary L, Creutzig A, Alexander K. Treatment of primary RaynaudŽs syndrome with traditional Chinese acupuncture.  J Intern Med. 1997;  241 119-124
• 3 Boin F, Wigley F M. Understanding, assessing and treating Raynaud’s phenomenon.  Curr Opin Rheumatol. 2005;  17 752-760
• 4 Bukhari M, Hollis S, Moore T, Jayson M IV, Herrick A L. Quantitation of microcircular abnormalities in patients with primary Raynaud’s phenomenon and systemic sclerosis by video capillaroscopy.  Rheumatology. 2000;  39 506-512
• 5 Cazelets C, Cador B, Rolland Y. et al . Exploration de la microcirculation pulpaire par écho-Doppler digitale chez des patients présentant une maladie de Raynaud ou une sclérocermie.  J Mal Vasc. 2004;  29 12-20
• 6 Coleiro B, Marshall S E, Denton C P. et al . Treatment of Raynaud’s phenomenon with the selective serotonin reuptake inhibitor fluoxetin.  Rheumatology. 2001;  40 1038-1043
• 7 Creutzig A, Freund M, Caspary L, Alexander K. Microangiopathy in patients with chronic myelogenous leukemia treated with interferon.  Microvasc Res. 1996;  52 288-292
• 8 Czupryniak A, Kaluzynska A, Nowicki M. et al . Raynaud’s Phenomenon and Endothelial Dysfunction in End-Stage Renal Disease Patients Treated with Hemodialysis.  Kidney Blood Press Res. 2005;  28 27-31
• 9 Gemne G, Pyykkö I, Taylor W. et al . The Stockholm Workshop scale for the classification of cold-induced Raynaud’s phenomenon in the hand-arm vibration syndrome (revision of the Taylor-Pelmaer scale).  Scand J Work Environ Health. 1987;  13 275-278
• 10 Marasini B, Massarotti M, Bottasso B. et al . Comparison between iloprost and alprostadil in the treatment of Raynaud’s phenomenon.  Scand J Rheumatol. 2004;  33 253-256
• 11 Rosenkranz S, Caglayan E, Diet F. et al . Langzeiteffekte von Sildenafil bei Sklerodermie-assoziierter pulmonaler Hypertonie und Raynaud-Syndrom.  Dtsch Med Wochenschr. 2004;  129 1736-1740
• 12 Thompson A E, Pope J E. Calcium channel blockers for primary Raynaud’s phenomenon: a meta-analysis.  Rheumatology. 2005;  44 145-150
• 13 von Bierbrauer A, Schilk I, Lucke C, Schmidt J A. Infrared thermography in the diagnosis of Raynaud’s phenomenon in vibration-induced white finger.  Vasa. 1998;  27 94-99
• 14 Wörnle M, Tatò F, Hoffmann U. Hypothenar-Hammer-Syndrom als Ursache einer schweren digitalen Ischämie.  Dtsch Med Wochenschr. 2004;  129 2352-2355
• 15 Zandman-Goddard G, Tweezer-Zaks N, Shoenfeld Y. New therapeutic strategies for systemic sclerosis - a critical analysis of the literature.  Clin Dev Immunol. 2005;  12 165-173